Moderna gets funding for an HPAI vaccine in humans

The U.S. government will give pharmaceutical company Moderna $176 million for a High Path Avian Flu vaccine, according to Reuters.

It uses the same technology as the COVID-19 vaccine, and Moderna began development and testing it last year on adults.

“mRNA vaccine technology offers advantages in efficacy, speed of development and production, scalability, and reliability in addressing infectious disease outbreaks, as demonstrated during the COVID-19 pandemic,” said Moderna CEO Stephane Bancel.

So far, four agriculture workers have contracted the virus since 2022.

Related Stories

The Rural Rundown

RURAL RUNDOWN: Thursday, Feb. 27, 2025

Here are the top agriculture news headlines from RFD-TV News today (Thursday, Feb. 27, 2025) and the top trending stories on RFD-TV News.

February 27, 2025 06:06 PM

Charlsie McKay

High-Path Avian Flu

“We Have to Start Somewhere": Industry leaders respond to Ag Sec. Rollins’ HPAI strategy

February 27, 2025 10:02 AM

RFD-TV News Staff

High-Path Avian Flu

Ohio reports the second largest culling this year due to HPAI

February 26, 2025 11:36 AM

RFD-TV News Staff

High-Path Avian Flu

Ag Secretary Brooke Rollins announces strategy to combat High-Path Avian Flu

U.S. Secretary of Agriculture Brooke Rollins announced her five-point comprehensive strategy to fight High-Path Avian Flu (HPAI) on Wednesday in an op-ed published in the Wall Street Journal.

February 26, 2025 10:05 AM

RFD-TV News Staff